Literature DB >> 24044873

Synthesis and antimicrobial activity of polyhalobenzonitrile quinazolin-4(3H)-one derivatives.

Li-Ping Shi1, Kun-Ming Jiang, Jun-Jie Jiang, Yi Jin, Yun-Hai Tao, Ke Li, Xing-Hong Wang, Jun Lin.   

Abstract

A novel series of polyhalobenzonitrile quinazolin-4(3H)-one derivatives were synthesized and characterized by NMR, IR, MS, and HRMS spectra. All of the newly prepared compounds were screened for antimicrobial activities against four strains of bacteria (Gram-positive bacterial: Staphylococcus aureus and Bacillus cereus; Gram-negative bacterial: Escherichia coli and Pseudomonas aeruginosa) and one strain of fungi (Candida albicans). Among the synthesized compounds, 5-(dimethylamino)-8-(2,4,5-trichloro-isophthalonitrile) quinazolin-4(3H)-one (7k) exhibited significant activity towards Gram-positive bacterial, Gram-negative bacterial, and the fungi strains. The MIC (0.8-3.3μg/mL) and MBC (2.6-7.8μg/mL) for this compound were close to those of nofloxacin, chlorothalonil, and fluconazole, making it the most potent antimicrobial agents in the series.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial activity; Fungi strains; Gram-negative bacterial; Gram-positive bacterial; Polyhalobenzonitrile quinazolin-4(3H)-one; Synthesis

Mesh:

Substances:

Year:  2013        PMID: 24044873     DOI: 10.1016/j.bmcl.2013.08.068

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Crystal structure of 2-benzamido-N-(2,2-di-eth-oxy-eth-yl)benzamide.

Authors:  Abdelaaziz Ouahrouch; Moha Taourirte; Hassan B Lazrek; Joachim W Engels; Michael Bolte
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-02-28

Review 2.  Quinazolinone and quinazoline derivatives: recent structures with potent antimicrobial and cytotoxic activities.

Authors:  Elham Jafari; Marzieh Rahmani Khajouei; Farshid Hassanzadeh; Gholam Hossein Hakimelahi; Ghadam Ali Khodarahmi
Journal:  Res Pharm Sci       Date:  2016 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.